Diagnostic tests are essential for containing COVID-19, and the World Health Organization (WHO) has urged health agencies to consider testing a top priority. It is in this context that Helena Gonçalves, Abel Duarte, and Eulália Pereira, from the Nanoplatforms research group, participate in a research project for COVID-19. The project entitled Cdots Biosensing COVID19 was awarded by the Foundation of Science and Technology with 30,000 €. The focus of the project is to develop a fast and low-cost biosensor to detect the presence of coronavirus in biological samples.
Cdots Biosensing COVID19 is a consortium of several universities and research institutes, including the University of Trás-os-Montes and Alto Douro (UTAD), the Network of Chemistry and Technology (REQUIMTE), the Polytechnic of Porto – School of Engineering (ISEP), the Institute of Public Health of the University of Porto (ISPUP), the Abel Salazar Institute of Biomedical Sciences (ICBAS), the Clinical Pathology Service of the Hospital Centre of Trás-os-Montes and Alto Douro, and the Clinical Pathology Centre of the University Hospital Centre of Cova da Beira.
“Research 4 COVID-19” is an exceptional funding call from FCT, in collaboration with the Agency for Clinical Research and Biomedical Innovation (AICIB), to short R&D projects and initiatives that consider the needs of the National Health Services in this fight against COVID-19.